363
landing page
MI Health
MI Health bridges innovation gaps across the health and health-care continuum. We advance whole-pers
on health throughout the life span by improving healthy aging, public health, biomedical science, and food systems., Future of Health Summit Panels
The Milken Institute Future of Health Summit brought together hundreds of leaders from across sectors to discuss critical issues and solutions within reach for ,
,
+ Read More
landing page
Frontotemporal Dementia
Frontotemporal Dementia
Frontotemporal dementia (FTD) describes brain conditions characterized by p
rogressive degeneration of the brain’s frontal and temporal lobes., About the Kissick Family Foundation FTD Grant Program
The Kissick Family Foundation partnered with MI Philanthropy’s Science and Health team in 2022 to analyze and understand the state of the FTD research ecosystem and identify where phi,
, Please
+ Read More
landing page
Livestream | 2023 Future of Health Summit
Looking for a session? Scroll down this page to find it. Looking for Program details? Find them
here.
+ Read More
landing page
Science Philanthropy Accelerator for Research and Collaboration
Who We Are
$30 billion in philanthropic funds are spent annually to advance medical research for tr
eatments and cures., Partner with Us
Leverage our strategic advisory service, scientific experts, and the breadth of the Milken Institute network to ensure your philanthropic resources advance medical solutions.
+ Read More
landing page
Center for Public Health Advisory Board
Paul Chew
President, 1Rx DigiPharm Advisory, LLC
landing page
Global Conference 2022
report
Learning from COVID-19: Reimagining Public-Private Partnerships in Public Health
The Milken Institute Center for Public Health leveraged our network of thought leaders to maximize
learnings from the COVID-19 pandemic, focused on examining the private sector’s role and responsibility in supp
+ Read More
report
Strengthening the Biomedical Innovation Ecosystem: A Scorecard for System Assessment
As patients, we often evaluate our interactions within the "system" of biomedical innovation with a
simple question: "Did it work for me?" This evaluation considers many issues, including whether the best treatments are accessible and available, how the
+ Read More
report
Cell and Gene Therapies: Looking Ahead to 2022
Cell and gene therapies are a new category of medicines transforming how we treat and potentially c
ure disease. Both cell and gene therapies seek to modify genetic material to fight disease.
+ Read More
report
A Blueprint for Administrative Reform of the Housing Finance System
This paper sets out proposed administrative actions to reform the housing finance system in the abs
ence of legislation.
+ Read More
report
Policy Issue Brief: A Call to Action for Diversity in Clinical Trials
FasterCures has initiated a body of work to advance system change within biomedical research to foc
us on and value diversity and representation within clinical trials.
+ Read More
report
Roadmap for Investment in Dementia Care
On average, people with Alzheimer’s disease and frontotemporal dementia live six to ten years after
diagnosis. People with vascular dementia and Lewy body dementia live on average five to six years after diagnosis.
+ Read More